C F Samer, K Ing Lorenzini, V Rollason, Y Daali, J A Desmeules. Mol Diagn Ther 2013
Times Cited: 191
Times Cited: 191
Times Cited
Times Co-cited
Similarity
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Ulrich M Zanger, Matthias Schwab. Pharmacol Ther 2013
Ulrich M Zanger, Matthias Schwab. Pharmacol Ther 2013
27
Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
M Bosilkovska, C F Samer, J Déglon, M Rebsamen, C Staub, P Dayer, B Walder, J A Desmeules, Y Daali. Clin Pharmacol Ther 2014
M Bosilkovska, C F Samer, J Déglon, M Rebsamen, C Staub, P Dayer, B Walder, J A Desmeules, Y Daali. Clin Pharmacol Ther 2014
18
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
Magnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, Cristina Rodriguez-Antona. Pharmacol Ther 2007
14
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
13
Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
13
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
Marija Bosilkovska, Julien Déglon, Caroline Samer, Bernhard Walder, Jules Desmeules, Christian Staub, Youssef Daali. Bioanalysis 2014
Marija Bosilkovska, Julien Déglon, Caroline Samer, Bernhard Walder, Jules Desmeules, Christian Staub, Youssef Daali. Bioanalysis 2014
27
Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
10
Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
10
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
10
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
9
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
Y Zhou, M Ingelman-Sundberg, V M Lauschke. Clin Pharmacol Ther 2017
Y Zhou, M Ingelman-Sundberg, V M Lauschke. Clin Pharmacol Ther 2017
9
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
M Ingelman-Sundberg. Pharmacogenomics J 2005
M Ingelman-Sundberg. Pharmacogenomics J 2005
9
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
9
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Shu-Feng Zhou. Clin Pharmacokinet 2009
Shu-Feng Zhou. Clin Pharmacokinet 2009
8
The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
8
7
Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay. Drug Metab Rev 2009
Shu-Feng Zhou, Jun-Ping Liu, Balram Chowbay. Drug Metab Rev 2009
7
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Ulrich M Zanger, Miia Turpeinen, Kathrin Klein, Matthias Schwab. Anal Bioanal Chem 2008
Ulrich M Zanger, Miia Turpeinen, Kathrin Klein, Matthias Schwab. Anal Bioanal Chem 2008
7
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Shu-Feng Zhou. Clin Pharmacokinet 2009
Shu-Feng Zhou. Clin Pharmacokinet 2009
7
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
L DiAnne Bradford. Pharmacogenomics 2002
L DiAnne Bradford. Pharmacogenomics 2002
7
Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.
Muh Akbar Bahar, Didik Setiawan, Eelko Hak, Bob Wilffert. Pharmacogenomics 2017
Muh Akbar Bahar, Didik Setiawan, Eelko Hak, Bob Wilffert. Pharmacogenomics 2017
10
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
M C Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, J Chabert, P Dayer, D Hochstrasser, M F Rossier. Pharmacogenomics J 2009
M C Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, J Chabert, P Dayer, D Hochstrasser, M F Rossier. Pharmacogenomics J 2009
6
A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.
Mallorie Clement Jerdi, Youssef Daali, Mitsuko Kondo Oestreicher, Samir Cherkaoui, Pierre Dayer. J Pharm Biomed Anal 2004
Mallorie Clement Jerdi, Youssef Daali, Mitsuko Kondo Oestreicher, Samir Cherkaoui, Pierre Dayer. J Pharm Biomed Anal 2004
10
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
Adrián LLerena, Maria Eugenia G Naranjo, Fernanda Rodrigues-Soares, Eva M Penas-LLedó, Humberto Fariñas, Eduardo Tarazona-Santos. Expert Opin Drug Metab Toxicol 2014
Adrián LLerena, Maria Eugenia G Naranjo, Fernanda Rodrigues-Soares, Eva M Penas-LLedó, Humberto Fariñas, Eduardo Tarazona-Santos. Expert Opin Drug Metab Toxicol 2014
6
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
Marija Bosilkovska, Caroline Samer, Julien Déglon, Aurélien Thomas, Bernhard Walder, Jules Desmeules, Youssef Daali. Basic Clin Pharmacol Toxicol 2016
Marija Bosilkovska, Caroline Samer, Julien Déglon, Aurélien Thomas, Bernhard Walder, Jules Desmeules, Youssef Daali. Basic Clin Pharmacol Toxicol 2016
20
Cytochrome P450 variations in different ethnic populations.
Joseph McGraw, Donald Waller. Expert Opin Drug Metab Toxicol 2012
Joseph McGraw, Donald Waller. Expert Opin Drug Metab Toxicol 2012
6
Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Palrasu Manikandan, Siddavaram Nagini. Curr Drug Targets 2018
Palrasu Manikandan, Siddavaram Nagini. Curr Drug Targets 2018
6
Regulation of drug-metabolizing enzymes and transporters in inflammation.
Alison E Aitken, Terrilyn A Richardson, Edward T Morgan. Annu Rev Pharmacol Toxicol 2006
Alison E Aitken, Terrilyn A Richardson, Edward T Morgan. Annu Rev Pharmacol Toxicol 2006
6
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Tom Lynch, Amy Price. Am Fam Physician 2007
Tom Lynch, Amy Price. Am Fam Physician 2007
6
Predicting in vivo drug interactions from in vitro drug discovery data.
Larry C Wienkers, Timothy G Heath. Nat Rev Drug Discov 2005
Larry C Wienkers, Timothy G Heath. Nat Rev Drug Discov 2005
6
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
5
Drug metabolism and variability among patients in drug response.
Grant R Wilkinson. N Engl J Med 2005
Grant R Wilkinson. N Engl J Med 2005
5
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
Roseann S Gammal, Kristine R Crews, Cyrine E Haidar, James M Hoffman, Donald K Baker, Patricia J Barker, Jeremie H Estepp, Deqing Pei, Ulrich Broeckel, Winfred Wang,[...]. Pediatrics 2016
Roseann S Gammal, Kristine R Crews, Cyrine E Haidar, James M Hoffman, Donald K Baker, Patricia J Barker, Jeremie H Estepp, Deqing Pei, Ulrich Broeckel, Winfred Wang,[...]. Pediatrics 2016
10
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping.
D Frank, U Jaehde, U Fuhr. Eur J Clin Pharmacol 2007
D Frank, U Jaehde, U Fuhr. Eur J Clin Pharmacol 2007
5
CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.
D-P Dai, R-A Xu, L-M Hu, S-H Wang, P-W Geng, J-F Yang, L-P Yang, J-C Qian, Z-S Wang, G-H Zhu,[...]. Pharmacogenomics J 2014
D-P Dai, R-A Xu, L-M Hu, S-H Wang, P-W Geng, J-F Yang, L-P Yang, J-C Qian, Z-S Wang, G-H Zhu,[...]. Pharmacogenomics J 2014
6
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
Magnus Ingelman-Sundberg. Trends Pharmacol Sci 2004
Magnus Ingelman-Sundberg. Trends Pharmacol Sci 2004
5
Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
5
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl-Carrillo, W Fraser Symmans, Howard L McLeod, Mark J Ratain, Hitoshi Zembutsu,[...]. Clin Pharmacol Ther 2018
Matthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Matthias Schwab, Michael Province, Michelle Whirl-Carrillo, W Fraser Symmans, Howard L McLeod, Mark J Ratain, Hitoshi Zembutsu,[...]. Clin Pharmacol Ther 2018
5
Pharmacogenomics and individualized drug therapy.
Michel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans. Annu Rev Med 2006
Michel Eichelbaum, Magnus Ingelman-Sundberg, William E Evans. Annu Rev Med 2006
5
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
J Kirchheiner, K Nickchen, M Bauer, M-L Wong, J Licinio, I Roots, J Brockmöller. Mol Psychiatry 2004
5
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives.
Flavia Storelli, Caroline Samer, Jean-Luc Reny, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2018
Flavia Storelli, Caroline Samer, Jean-Luc Reny, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2018
29
Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
Gaëlle Magliocco, Aurélien Thomas, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2019
Gaëlle Magliocco, Aurélien Thomas, Jules Desmeules, Youssef Daali. Clin Pharmacokinet 2019
20
Drug Metabolism in the Liver.
Omar Abdulhameed Almazroo, Mohammad Kowser Miah, Raman Venkataramanan. Clin Liver Dis 2017
Omar Abdulhameed Almazroo, Mohammad Kowser Miah, Raman Venkataramanan. Clin Liver Dis 2017
5
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
Katherine N Theken, Craig R Lee, Li Gong, Kelly E Caudle, Christine M Formea, Andrea Gaedigk, Teri E Klein, José A G Agúndez, Tilo Grosser. Clin Pharmacol Ther 2020
Katherine N Theken, Craig R Lee, Li Gong, Kelly E Caudle, Christine M Formea, Andrea Gaedigk, Teri E Klein, José A G Agúndez, Tilo Grosser. Clin Pharmacol Ther 2020
6
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.
Célia Lloret-Linares, Victoria Rollason, Kuntheavy Ing Lorenzini, Caroline Samer, Youssef Daali, Marianne Gex-Fabry, Jean-Michel Aubry, Jules Desmeules, Marie Besson. Pharmacol Res 2017
Célia Lloret-Linares, Victoria Rollason, Kuntheavy Ing Lorenzini, Caroline Samer, Youssef Daali, Marianne Gex-Fabry, Jean-Michel Aubry, Jules Desmeules, Marie Besson. Pharmacol Res 2017
62
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
Camille Lenoir, Youssef Daali, Victoria Rollason, François Curtin, Yvonne Gloor, Marija Bosilkovska, Bernhard Walder, Cem Gabay, Michael John Nissen, Jules Alexandre Desmeules,[...]. Clin Pharmacol Ther 2021
Camille Lenoir, Youssef Daali, Victoria Rollason, François Curtin, Yvonne Gloor, Marija Bosilkovska, Bernhard Walder, Cem Gabay, Michael John Nissen, Jules Alexandre Desmeules,[...]. Clin Pharmacol Ther 2021
33
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients.
Y Daali, S Cherkaoui, F Doffey-Lazeyras, P Dayer, J A Desmeules. J Chromatogr B Analyt Technol Biomed Life Sci 2008
Y Daali, S Cherkaoui, F Doffey-Lazeyras, P Dayer, J A Desmeules. J Chromatogr B Analyt Technol Biomed Life Sci 2008
20
CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
Dana Ravyn, Vipa Ravyn, Robert Lowney, Henry A Nasrallah. Schizophr Res 2013
Dana Ravyn, Vipa Ravyn, Robert Lowney, Henry A Nasrallah. Schizophr Res 2013
6
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
C F Samer, Y Daali, M Wagner, G Hopfgartner, C B Eap, M C Rebsamen, M F Rossier, D Hochstrasser, P Dayer, J A Desmeules. Br J Pharmacol 2010
C F Samer, Y Daali, M Wagner, G Hopfgartner, C B Eap, M C Rebsamen, M F Rossier, D Hochstrasser, P Dayer, J A Desmeules. Br J Pharmacol 2010
4
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.